Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 USD | -3.57% | +20.43% | +31.46% |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Sales 2020 | - | Sales 2021 | - | Capitalization | 29.41M 2.45B |
---|---|---|---|---|---|
Net income 2020 | -4M -334M | Net income 2021 | -5M -417M | EV / Sales 2020 | - |
Net Debt 2020 | 399K 33.3M | Net cash position 2021 | 670K 55.92M | EV / Sales 2021 | - |
P/E ratio 2020 |
-2.11
x | P/E ratio 2021 |
-1.44
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.95% |
1 week | +10.66% | ||
Current month | -3.57% | ||
1 month | -3.57% | ||
3 months | +8.00% | ||
6 months | +162.14% | ||
Current year | +26.76% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/21/11 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/22/12 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.027 | -3.57% | 75,915 |
26/24/26 | 0.028 | +11.11% | 5,000 |
25/24/25 | 0.0252 | -9.68% | 76,000 |
24/24/24 | 0.0279 | +9.63% | 10,700 |
23/24/23 | 0.0254 | +4.30% | 197,414 |
Delayed Quote OTC Markets, April 30, 2024 at 12:49 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- CUBT Stock
- CUBT Stock